| Literature DB >> 29263119 |
Coen C W G Bongers1, Mohammad Alsady2, Tom Nijenhuis3, Yvonne A W Hartman1, Thijs M H Eijsvogels1,4, Peter M T Deen5, Maria T E Hopman1.
Abstract
Exercise may lead to kidney injury through several mechanisms. Urinary Kidney Injury Molecule-1 (uKIM1) and Neutrophil Gelatinase-Associated Lipocalin (uNGAL) are known biomarkers for acute kidney injury, but their response to repetitive exercise remains unknown. We examined the effects of a single versus repetitive bouts of exercise on markers for kidney injury in a middle-aged population. Sixty subjects (aged 29-78 years, 50% male) were included and walked 30, 40 or 50 km for three consecutive days. At baseline and after exercise day 1 and 3, a urine sample was collected to determine uNGAL and uKIM1. Furthermore, urinary cystatin C, creatinine, and osmolality were used to correct for dehydration-related changes in urinary concentration. Baseline uNGAL was 9.2 (5.2-14.7) ng/mL and increased to 20.7 (11.0-37.2) ng/mL and 14.2(8.0-26.3) ng/mL after day 1 and day 3, respectively, (P ≤ 0.001). Baseline uKIM1 concentration was 2.6 (1.4-6.0) ng/mL and increased to 5.2 (2.4-9.1) ng/mL (P = 0.002) after day 1, whereas uKIM1 was not different from baseline at day 3 (2.9 [1.4-6.4] ng/mL (P = 0.52)). Furthermore, both uNGAL and uKIM1 levels were higher after day 1 compared to day 3 (P < 0.01). When corrected for urinary cystatin C, creatinine, and osmolality, uNGAL demonstrated a similar response compared to the uncorrected data, whereas differences in uKIM1 between baseline, day 1 and day 3 (Ptime = 0.63) were no longer observed for cystatin C and creatinine corrected data. A single bout of prolonged exercise significantly increased uNGAL concentration, whereas no changes in uKIM1 were found. Repetitive bouts of exercise show that there is no cumulative effect of kidney injury markers.Entities:
Keywords: Kidney Injury Molecule‐1; neutrophil Gelatinase‐Associated Lipocalin; prolonged Exercise; renal Injury
Mesh:
Substances:
Year: 2017 PMID: 29263119 PMCID: PMC5742704 DOI: 10.14814/phy2.13544
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Baseline subject characteristics (n = 60)
| Parameter | Value |
|---|---|
| Sex (male:female) | 30: 30 |
| Age (years) | 56 ± 10 |
| Length (m) | 173 ± 8 |
| Body mass (kg) | 75.4 ± 13.8 |
| BMI (kg/m2) | 24.9 ± 3.0 |
| Fat percentage (%) | 31.2 ± 5.5 |
| Systolic blood pressure (mmHg) | 138 ± 20 |
| Diastolic blood pressure (mmHg) | 85 ± 11 |
| Resting heart rate (bpm) | 63 ± 7 |
| eGFR (mL/min·1.73 m2) | 89.3 ± 11.6 |
| Activity score (au) | 6965 ± 3462 |
| MET min a day (MET min) | 1027 ± 502 |
Subject characteristics for the total group. Data were presented as mean ± SD. MET, Metabolic equivalent of task; bpm, beats per minute; au, arbitrary unit.
Exercise characteristics and fluid balance parameters at baseline and after day 1 and day 3
| Baseline | Day 1 | Day 3 |
| |
|---|---|---|---|---|
| Exercise characteristics | ||||
| Exercise duration (hh:mm) | – | 8:10 ± 1:59 | 8:28 ± 1:53 | 0.29 |
| Average HR (bpm) | – | 112 ± 14 | – | – |
| Exercise intensity (% of HR max) | – | 70.8 ± 8.9 | – | – |
| Walking speed (km/h) | – | 4.8 ± 0.7 | 4.7 ± 0.7 | 0.22 |
| WBGT (°C) | – | 21.1 ± 1.5 | 17.6 ± 2.5 |
|
| Relative humidity (%) | – | 71.4 ± 14.9 | 67.5 ± 19.6 | 0.08 |
| Fluid balance | ||||
| Fluid intake (mL/h) | – | 309 ± 121 | 300 ± 133 | 0.48 |
| Water (%) | – | 50.7 ± 22.2 | 48.1 ± 21.0 | 0.26 |
| Other (%) | – | 49.3 ± 22.2 | 51.9 ± 21.0 | 0.26 |
| Urine osmolality (mOsm/mL) | 890 (589–1113) | 998 (719–1159) | 945 (649–1264) | 0.36 |
| Hemoglobin (mmol/L) | 15.2 ± 1.4 | 15.5 ± 1.5 | 14.8 ± 1.5 |
|
| Hematocrit (L/L) | 44.8 ± 4.2 | 45.6 ± 4.4 | 43.5 ± 4.5 |
|
| Plasma volume change (%) | – | –2.9 ± 8.5 | 5.8 ± 10.7 |
|
| Plasma sodium (mmol/L) | 141.2 ± 1.6 | 143.4 ± 2.4 | 141.4 ± 2.0 |
|
| Prevalence of hyponatremia (n(%)) | 0 (0%) | 0 (0%) | 0 (0%) | 1.00 |
| Prevalence of hypernatremia (n(%)) | 1 (1.7%) | 18 (30%) | 2 (3.3%) |
|
| Body mass change (kg) | – | −0.8 ± 1.0 | −0.4 ± 0.5 |
|
| Body mass change (%) | – | −0.9 ± 1.2 | –0.4 ± 0.7 |
|
| Dehydration; ≥2% body mass loss (n(%)) | – | 12 (20%) | 0 (0%) |
|
| Inflammation | ||||
| Plasma IL‐6 (pg/mL) | 0.5 (0.3–0.6) | 5.2 (3.4–8.4) | 2.0 (1.5–3.5) |
|
| TNF‐ | 1.53 (1.3–1.8) | 1.6 (1.4–1.9) | 1.5 (1.3–1.7) |
|
Exercise characteristics and fluid balance at baseline, after exercise day 1 and day 3. Data were presented as mean ± SD or median (IQR). P‐values represents the results of the one‐way ANOVA or nonparametric alternative.
Significantly different from baseline.
Significantly different from day 1.
A nonparametric alternative was used: Friedman test for time‐effect and Wilcoxon signed‐ranks test for differences between individual days.
Figure 1Effect of acute and repetitive bouts of prolonged exercise on uNGAL concentration (n = 60). The uncorrected data are presented (A), as well as after correction for cystatin C (B), creatinine (C) and osmolality (D). A significant increase in NGAL concentration compared to baseline was found after day 1 and 3. A Friedman test was used to examine differences over time, whereas a Wilcoxon signed‐rank test was used to assess differences between days. Data were presented as median with interquartile range. *Represents a significant difference (P < 0.05) from baseline.
Figure 2Effect of acute and repetitive bouts of prolonged exercise on uKIM1 concentration (n = 60). The uncorrected data are presented (A), as well as after correction for cystatin C (B), creatinine (C) and osmolality (D). Increased uKIM1 levels after day 1 compared to baseline were found for the uncorrected and osmolality corrected data, whereas no differences in uKIM1 between days were found after cystatin C and creatinine correction. A Friedman test was used to examine differences over time, and a Wilcoxon signed‐rank test was used to assess differences between days. Data were presented as median with interquartile range. * Represents a significant difference (P < 0.05) from baseline, and † represents a difference from day 1.
Renal injury markers at baseline and after day 1 and day 3
| Baseline | Day 1 | Day 3 |
| |
|---|---|---|---|---|
| Urine Cystatin C (mg/L) | 0.05 (0.03–0.08) | 0.09 (0.05–0.12) | 0.06 (0.03–0.09) | <0.001 |
| Urine Creatinine (mmol/L) | 8.1 (5.4–13.3) | 11.6 (7.9–17.9) | 6.8 (4.6–13.1) | <0.001 |
| Serum Creatinine ( | 75.3 ± 13.7 | 86.9 ± 22.8 | 75.5 ± 15.0 | <0.001 |
| Proteinuria | 0.39 | |||
| Negative (0 g/L) (n(%)) | 58 (96.7%) | 52 (86.7%) | 55 (91.7%) | |
| Trace (0.15 g/L) (n(%)) | 2 (3.3%) | 3 (5%) | 2 (3.3%) | |
| +(0.3 g/L) (n(%)) | 0 (0%) | 4 (6.7%) | 3 (5%) | |
| ++(1 g/L) (n(%)) | 0 (0%) | 1 (1.7%) | 0 (0%) | |
Renal injury markers at baseline, after exercise day 1 and day 3. Data were presented as median (IQR).
Significantly different from baseline.
Significantly different from day 1.
A nonparametric alternative was used: Friedman test for time‐effect and Wilcoxon signed‐rank test for differences between individual days.